3-Methylcyclopentanone is a cyclic ketone with a methyl substituent at the 3-position. It is a colorless liquid with a pungent odor. It is used as an intermediate in the synthesis of various organic compounds. 3-Methylcyclopentanone has been investigated for its potential use as a fuel additive and as a building block in the synthesis of pharmaceuticals and agrochemicals. It is also of interest in the study of organic reactions and mechanisms. '
```
| ID Source | ID |
|---|---|
| PubMed CID | 15650 |
| CHEBI ID | 195512 |
| MeSH ID | M0511783 |
| Synonym |
|---|
| 3-methyl-cyclopentan-1-one |
| nsc25212 |
| cyclopentanone, 3-methyl- |
| 1757-42-2 |
| 3-methyl-1-cyclopentanone |
| nsc-25212 |
| 3-methylcyclopentanone |
| 3-methylcyclopentanone, 99% |
| 3-methylcyclopentan-1-one |
| CHEBI:195512 |
| AKOS005255221 |
| n603804p52 , |
| unii-n603804p52 |
| nsc 25212 |
| dl-3-methylcyclopentanone |
| einecs 217-148-9 |
| 3-methylcyclopentanone, (+/-)- |
| GEO-01805 |
| FT-0625404 |
| 3-methyl cyclopentanone |
| (r)-(+)-3-methyl-cyclopentanone |
| J-502099 |
| (+/-)-3-methylcyclopentanone |
| 1-methyl-3-cyclopentanone |
| mfcd00001416 |
| J-512899 |
| 3-methyl-cyclopentanone |
| SY003033 |
| AMY3874 |
| 3-methylcyclopentanone (2,2,5,5-d4) |
| Q27284587 |
| F10505 |
| DTXSID201023930 |
| CS-0015918 |
| EN300-51490 |
| Class | Description |
|---|---|
| cyclopentanones | Any alicyclic ketone that consists of a cyclopentane skeleton substituted by at least one oxo group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (36.06) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||